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Grx5 defines a family of yeast monothiol glutaredox-
ins that also includes Grx3 and Grx4. All three proteins
display significant sequence homology with proteins
found from bacteria to humans. Grx5 is involved in iron/
sulfur cluster assembly at the mitochondria, but the
function of Grx3 and Grx4 is unknown. Three-dimen-
sional modeling based on known dithiol glutaredoxin
structures predicted a thioredoxin fold structure for
Grx5. Positionally conserved amino acids in this glu-
taredoxin family were replaced in Grx5, and the effect
on the biological function of the protein has been tested.
For all changes studied, there was a correlation between
the effects on several different phenotypes: sensitivity
to oxidants, constitutive protein oxidation, ability for
respiratory growth, auxotrophy for a number of amino
acids, and iron accumulation. Cys60 and Gly61 are essen-
tial for Grx5 function, whereas other single or double
substitutions in the same region had no phenotypic ef-
fects. Gly115 and Gly116 could be important for the for-
mation of a glutathione cleft on the Grx5 surface, in
contrast to adjacent Cys117. Substitution of Phe50 alters
the -sheet in the thioredoxin fold structure and inhib-
its Grx5 function. None of the substitutions tested affect
the structure at a significant enough level to reduce
protein stability.
Glutaredoxins are thiol oxidireductases that catalyze redox
reactions involving reduced glutathione as a hydrogen donor
for the reduction of protein disulfides (dithiol mechanism of
action) or glutathione-protein-mixed disulfides (monothiol
mechanism of action) (see Refs. 1 and 2 for review). Previously
described glutaredoxins are small proteins (about 10 kDa) with
a conserved active site that includes two cysteine residues
(Cys-Pro-Tyr-Cys). Site-directed mutagenesis (3–5) has demon-
strated that both cysteine residues in the active site are re-
quired for the dithiol reaction. In contrast, the amino-terminal
cysteine is sufficient to catalyze the deglutathionylation of the
reduced glutathione-mixed disulfides that are formed under
oxidative stress conditions (5).
Three-dimensional structures of oxidized and reduced forms
of viral, bacterial, and mammalian glutaredoxins and also of
reduced glutathione-glutaredoxin complexes have been identi-
fied using x-ray crystallography (6, 7) or nuclear magnetic
resonance spectroscopy (8–14). These studies have revealed
which residues, apart from those at the active site, are impor-
tant for stable interactions between glutathione and the glu-
taredoxin molecule (10, 13, 14). Dithiol glutaredoxins are mem-
bers of the thioredoxin superfamily (15, 16) along with at least
five other classes of proteins that interact with cysteine-con-
taining substrates (thioredoxins, DbsA, protein disulfide
isomerases, glutathione S-transferases, and glutathione per-
oxidases). This superfamily shares a structural motif (called
the thioredoxin fold or  fold) formed by a four or five-
stranded -sheet (with parallel and antiparallel strands) sur-
rounded by three or more -helices distributed on either side of
the -sheet (15, 16). Thioredoxins share with glutaredoxins the
ability to reduce disulfides, although the former directly use
NADPH as hydrogen donor (1).
Dithiol glutaredoxins participate in a large number of func-
tions in prokaryotic and eukaryotic cells, including the activa-
tion of ribonucleotide reductase (17) and 3-phosphoadenylyl-
sulfate reductase (18), reduction of ascorbate (19), regulation of
the DNA binding activity of nuclear factors (20), and neuronal
protection against dopamine-induced apoptosis (21, 22). A fam-
ily of three Saccharomyces cerevisiae proteins (Grx3, Grx4, and
Grx5) has been described (23) that has significant homology
with dithiol glutaredoxins, preferentially at the carboxyl-ter-
minal region of the molecules. The absence of any of these
proteins leads to a decrease in cellular glutaredoxin activity,
even though they do not contain the conserved active site of
classic dithiol glutaredoxins. Instead, these proteins contain
the conserved Cys-Gly-Phe-Ser motif at the amino-terminal
region (23). This is the only cysteine residue found in Grx3 and
Grx4, whereas Grx5 has an additional cysteine at the carboxyl-
terminal moiety. From these data, it has been proposed that
Grx3, Grx4, and Grx5 constitute a family of monothiol glutare-
doxins in yeast (23). However, although there is a high degree
of homology among them, these three proteins seem to carry
out different cellular functions: the absence of Grx5 causes
dramatic sensitivity to oxidants and growth defects in minimal
medium, whereas no clear phenotypes are observed when Grx3
or Grx4 is absent. More recently, it has been shown that Grx5
is located at the mitochondria and involved in the biogenesis of
iron/sulfur clusters (24). Accumulation of cellular iron when
Grx5 is absent could lead to protein oxidation and sensitivity to
external oxidants. Available data about Grx3 and Grx4 indi-
cate that they are not located in the mitochondria (24).
Proteins homologous to yeast monothiol glutaredoxins exist
in all types of organisms from bacteria to humans (23, 25, 26).
The human homologue (PICOT1 protein) has been proposed as
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a negative regulator of protein kinase C- in the pathway
leading to activation of the activator protein 1 and nuclear
factor B transcription factors (27). The conserved region has
been termed PICOT homology domain, and in Grx5, it corre-
sponds to the majority of the peptide (23, 25). Human PICOT,
yeast Grx3 and Grx4, and other eukaryotic homologous pro-
teins possess amino-terminal extensions of PICOT homology
domain. These extensions have signatures characteristic of
thioredoxins or dithiol glutaredoxins that do not encompass the
oxidoreductase active site (25). All these observations support
the differential roles displayed by monothiol glutaredoxins re-
gardless of their structural similarities.
In this work, we show that Grx5 defines a ubiquitous family
of proteins whose members are present in most types of organ-
isms and are characterized by the presence of a thioredoxin fold
structure. We also demonstrate the essential biological roles of
a number of conserved amino acid residues, such as a cysteine
located at the previously proposed active site in the amino-
terminal region and a pair of glycines in the carboxyl-terminal
region.
EXPERIMENTAL PROCEDURES
Strains, Plasmids, and Amino Acid Replacements—CML235 (MATa
ura3-52 leu21 his3200) was used as wild-type strain. MML19 is an
isogenic grx5::kanMX4 derivative of CML235 (23). MML160 was ob-
tained from the latter by chromosomal integration of the YIplac211
vector (integrative, LEU2 marker) (28). MML161 was constructed sim-
ilarly, although a YIplac211-derived plasmid (pMM25) with GRX5 ex-
pressed under its own promoter was integrated at LEU2. Other strains
listed in Table I resulted from integration of pMM25-derived plasmids
carrying the indicated point mutations at the mutant leu2 locus of
MML19.
The following plasmids contain the cloned GRX5 open reading frame
(with the type of mutation in the translation product indicated in
parentheses) without further upstream or downstream sequences, un-
der the control of the doxycycline-regulatable tetO7 promoter in plasmid
pCM190 (29): pCM319 (wild-type GRX5), pMM176 (F50E), pMM113
(C60S), pMM155 (G61V), pMM127 (G115V), and pMM112 (G116V).
These plasmids were then transformed into strain CML276 (30), which
carries the doxycycline-inducible tetR-SSN6 repressor gene, to deter-
mine the stability of the Grx5 wild-type protein and the amino acid-
substituted derivatives.
Point mutations in the GRX5 open reading frame that yielded the
different amino acid replacements were constructed by the ExSite
method (31), using either pMM25 or pCM319 DNA as a template.
Oligonucleotides for PCR amplification were designed in such a way
that a restriction site that did not alter the translation product was
introduced near to the desired point mutation and used as a marker for
it. Successful introduction of the mutations was confirmed by DNA
sequencing.
Growth Conditions and Determination of Sensitivity to Menadione—
Cells were usually grown at 30 °C in rich YPD medium. Plasmid-
bearing transformants were grown in synthetic complete medium (32)
without the selective auxotrophic requirement. Plates of synthetic de-
fined medium (0.67% yeast nitrogen base, 2% glucose, and auxotrophic
requirements) were used to test mutant growth. Cells growing expo-
nentially in YPD medium at 30 °C (about 2  107 cells/ml) were treated
with menadione (10 mM) to determine sensitivity to it. After treatment,
1:5 serial dilutions were made, and drops were spotted onto YPD plates.
Growth was recorded after 2 days of incubation at 30 °C.
Analytical Methods—Protein carbonyl levels in crude cell extracts
were quantified according to the dinitrophenylhydrazine derivatization
method (23). Total iron cell content was determined under reducing
conditions, after acid digestion of cells using 3% nitric acid (33). Mean
cell volumes were determined in nonfixed cells using a Coulter Z2
counter to calculate cell iron concentration.
Determination of Protein Stability—Exponentially growing cells that
overexpressed GRX5 under the control of the tetO7 promoter were
added to doxycycline (20 g/ml) to interrupt gene expression. At suc-
cessive times, samples were taken, and total cell extracts were prepared
(24). Western analyses were carried out using a polyclonal antibody
prepared against Escherichia coli-expressed full-length Grx5 protein at
a 1:2500 dilution (24). In each experiment, equal amounts of total cell
protein (60 g) were run in parallel for each sample. The relative level
of Grx5 was determined from the intensity of the Grx5 band signal,
following quantification with the Lumi-Imager equipment (Roche Mo-
lecular Biochemicals) software.
Grx5 Structure Prediction—Protein structures related to Grx5 were
identified by applying the GenThreader fold recognition method (34).
Two structures offering maximal probability of correct match were
selected and collected from the Protein Data Bank (Protein Data Bank
accession numbers 1KTE and 3GRX). They respectively corresponded
to pig liver thioltransferase (7) and E. coli Grx3 glutaredoxin (14).
Different models of Grx5 based on these protein structures were ob-
tained using the Swiss-Model server (35, 36). Protein structures were
analyzed applying the Swiss-PDB Viewer program (35).
Protein Sequence Analyses—Grx5 amino acid sequence was com-
pared with proteins from the Institute for Chemical Research (Kyoto
University, Kyoto, Japan) and Swiss Protein Databases using FASTA
analysis provided by the two servers. Multiple sequences were aligned
using the ClustalW program (37) and the tools provided by the Euro-
pean Bioinformatics Institute. Internal gaps were not eliminated, and
the Blosum80 matrix option was used for alignment.
RESULTS
Yeast Grx5 Is a Member of a Ubiquitous Family of Proteins
Sharing the PICOT Domain—Yeast Grx5 has been character-
ized as a monothiol glutaredoxin-like protein whose amino acid
sequence displays extensive homology (particularly at what
have been designated its amino-terminal and carboxyl-termi-
nal regions) with a family of proteins whose members are
present in all living organisms from bacteria to humans (23,
25). The carboxyl-terminal region also has significant homology
with classic dithiol glutaredoxins (23). To extend these initial
studies, the Institute for Chemical Research and Swiss Protein
Databases were searched for proteins with the highest homol-
ogy with Grx5 (E value cutoff, 1 e10), using FASTA analysis.
We only considered proteins that retained the putative active
site CGFS sequence in the amino-terminal region (23) for com-
parison. The 35 protein sequences with the highest similarity
score with Grx5 were then aligned using the ClustalW program
(Fig. 1). A putative Grx5 homologue from Candida albicans, as
deduced from the genome sequence of the latter organism, was
also included for comparison. Extensions at the amino-terminal
and carboxyl-terminal ends (that are present only in some of
the family members (see below)) were omitted for the align-
ment. The existence of two amino-terminal and carboxyl-ter-
minal regions with extensive homology (23) (separated by a less
well-conserved region with a slightly variable length) was con-
firmed in this extended study.
Most multicellular eukaryotic members of the Grx5 family
have large amino-terminal extensions. This is also the case for
the S. cerevisiae Grx3 and Grx4 glutaredoxins and for one of
the two sequences in fission yeast (Fig. 1). This amino-terminal
extension includes a highly conserved duplication of the region
shown in Fig. 1 in the cases of human and rat species and in one
of the two mouse species (Q9JLZ2M) (Ref. 25 and this study).
Interestingly, the Arabidopsis thaliana protein Q9ZPH2A (but
not other members of the same protein family in this plant
species) contains three conserved domains in tandem, but only
the most carboxyl-terminal of these is shown in the Fig. 1
alignment. On the other hand, S. cerevisiae Grx5, the C. albi-
cans Grx5 homologous protein, the other fission yeast protein,
and all bacterial members of the family have shorter versions of
the protein without amino-terminal extensions.
The domain shown in the alignments is almost totally coin-
cident with the PICOT homology domain region named after
the human Grx5 homologue (25, 27). Our study shows that this
domain may be shared by proteins from prokaryotes (both
Archaea and bacteria) and eukaryotes. These proteins may
have divergent functions and different cellular locations.
A Thioredoxin Fold Structure Is Predicted for Grx5 Glutare-
doxin—Grx5 has sequence similarity with dithiol glutaredox-
ins, mostly at the carboxyl-terminal moiety (23). The three-
Structure-Function Analysis of Yeast Grx5 37591
 at U
N
IV
ERSITA
T D
E LLEID
A
 on June 30, 2015
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
dimensional structure of a number of dithiol glutaredoxins was
already known, from either x-ray crystallography or NMR spec-
troscopy studies. Structures in the Protein Data Bank were
used to construct a three-dimensional model for Grx5. Two
protein structures, pig liver thioltransferase (1KTE) (7) and
E. coli Grx3 glutaredoxin (3GRX) (14), yielded useful models for
Grx5. Amino acid sequences of these two proteins show 28%
and 29% identity to Grx5, respectively. Models based both
individually and simultaneously on 1KTE and 3GRX yielded
almost identical results for a large, carboxyl-terminal part of
the protein, which represented about two-thirds of the se-
quence. Differences in the amino-terminal part were attributed
to the poor quality of the 3GRX-based model because homology
of E. coli Grx3 to Grx5 is low in this region. The 1KTE structure
(Fig. 2A) was therefore finally taken as the basis for the Grx5
model (Fig. 2B), which is considered to provide a valid repre-
sentation of the Grx5 protein structure. The proposed model
shows an  fold typical of thiol oxidoreductases and other
enzymes from the superfamily (15). Four -helix segments are
predicted: amino acids 61–71 (1), 92–98 (2), 117–125 (3), and
129–135 (4) (Fig. 1, top row). For comparison, Fig. 2C shows
the structure of phage T4 glutaredoxin (1ABA) (6), which is one
of the simplest (structurally speaking) representatives of the
thioredoxin fold superfamily. The model shows that the simi-
larity between Grx5 and other proteins from the superfamily
extends to the amino-terminal moiety of the molecule.
Cys60, but Not Cys117, Is Essential for the Biological Activity
of Grx5—Grx5 contains two cysteine residues at positions 60
and 117. The first is part of a conserved sequence common to all
members of the family (Ref. 23; Fig. 1). It is exposed at the
surface of Grx5 between a -strand and 1 (Fig. 3). Cys
117 is
only present in certain family members (Fig. 1), although many
dithiol glutaredoxins also contain a cysteine residue in an
equivalent position (23). This cysteine is the first 3 residue
and follows two glycine residues that are conserved in all the
dithiol and monothiol glutaredoxins (Fig. 3; Ref. 23). Cys60 and
Cys117 were separately substituted by serine residues, and the
biological effects of these mutations were studied after reintro-
ducing the respective mutant Grx5 forms into a strain that was
devoid of the wild-type version. Initially, two phenotypes were
studied that had been shown to be affected in null grx5 mu-
tants (23): sensitivity to oxidative stress induced by menadione,
and defective growth in synthetic defined medium. Cells with
the C60S mutation in Grx5 behaved like those without the
protein, whereas those with the C117S change did not differ
with respect to wild-type cells (Fig. 4B). Therefore, the absence
of Cys60 annuls the biological activity of Grx5, whereas Cys117
is not essential for it. These results demonstrate that Cys60 is
the active residue for the oxidoreductase reaction and confirm
observations for two dithiol glutaredoxins, pig liver thioltrans-
ferase (4) and E. coli Grx3 (14), where the cysteine residues at
FIG. 1. ClustalW alignment of proteins displaying homology to S. cerevisiae Grx5. Amino-terminal and carboxyl-terminal extensions
were not considered for the alignment. Protein species are named according to their Swiss-Prot accession number, except for ml10053, which
corresponds to the Institute for Chemical Research accession number. The number at the left of the sequences indicates the position of the first
amino acid residue shown. The top row indicates the predicted secondary structure. The four predicted -helix regions are named according to the
nomenclature for thioredoxin fold structure (15). Abbreviations for organisms were as follows: Sc, S. cerevisiae; Ca, C. albicans; Sp, Schizosac-
charomyces pombe; Nm, Neisseria meningitidis; Hi, Haemophilus influenzae; Hd, Haemophilus ducreyi; Pm, Pasteurella multocida; Lp, Legionella
pneumophila; Pa, Pseudomonas aeruginosa; Ec, E. coli; Vc, Vibrio cholerae; Rp, Rickettsia prowazekii; Xf, Xylella fastidiosa; Ba, Buchnera
aphidicola; Ml, Mesorhizobium loti; Ha, Halobacterium sp.; Sy, Synechocystis sp.; Sn, Synechococcus sp.; Cc, Caulobacter crescentus; Pf, Plasmo-
dium falciparum; Lm, Leishmania major; Ce, Caenorhabditis elegans; Dm, Drosophila melanogaster; Pp, Porphyra purpurea; At, A. thaliana; Rn,
Rattus norvegicus; Mm, Mus musculus; and Hs, Homo sapiens.
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equivalent positions to Grx5 Cys117 were shown not to be re-
quired for the glutaredoxin activity.
A Number of Conserved Residues Are Important for Grx5
Activity—Besides Cys60 and Cys117, other residues are also
conserved in the Grx5 sequence as revealed by comparison with
the other family members. We introduced a number of single
and double point mutations into GRX5 (Fig. 4A; Table I) that
changed the amino acid residues in the putative active site
region. Changes were also introduced in other amino acids that
were presumably important for maintaining the three-dimen-
sional structure of Grx5. Thus, according to the proposed model
(Fig. 3), the F50E mutation could alter a -strand that is part
of the active site cleft of Grx5. The G115V and G116V changes
alter a glycine pair that is conserved in all dithiol and mono-
thiol glutaredoxins (23). This pair is probably important for the
proper orientation of 3 relative to 1 and Cys
60 (Fig. 3). Of the
single and double amino acid changes in the conserved CFGS
region, only the G61V change caused biological inactivation of
Grx5 (Fig. 4C). In contrast, the F50E and the single G115V and
G116V mutations annulled the biological activity of Grx5. Less
bulky side chains were also used for Gly61 or Gly115 substitu-
tions. In both cases, introduction of an alanine residue main-
tained the wild-type phenotype, whereas serine disrupted the
biological activity of the protein (Fig. 4C). We concluded that
some but not all of the conserved residues in the Grx5 family
are essential for the activity of the protein.
Loss of GRX5 causes other phenotypic effects besides those
described above, including the accumulation of cellular iron
and the constitutive carbonylation of cell proteins (23, 24).
Increased iron concentration in grx5 cells has been associated
with a rise in the number of protein carbonyl groups, which is
an indicator of oxidative damage to protein (24). Thus, we
determined whether the mutations that caused an increase in
menadione sensitivity or inhibited growth in minimal medium
also resulted in the previously mentioned phenotypes. In fact,
all the Grx5 mutants studied that were hypersensitive to oxi-
dative stress contained higher levels of iron than wild-type cells
or mutants not affected in oxidative stress sensitivity (Fig. 5).
Amino acid substitutions that caused increased intracellular
iron resulted in an increase of about 50% in total carbonyl
groups in cell proteins, whereas amino acid changes such as
C117S did not affect other cell phenotypes (Table II).
Grx5 Stability Is Not Affected in the Mutants—It is expected
that a significant change in the structure of Grx5 due to amino
acid substitutions could alter the protein stability. Changes in
the half-life of Grx5 would therefore be indicative of significant
modifications in protein tertiary structure. To determine the
half-life of Grx5, we used the doxycycline-regulatable tTA ac-
tivator/Ssn6 repressor dual system (30) that allows strong pro-
moter repression upon antibiotic addition. In fact, Northern
analysis (data not shown) demonstrated that in CML276 cells
(where the chromosomal-integrated SSN6 repressor gene is
activated by doxycycline) transformed with pCM319 plasmid
carrying the tet-GRX5 construction (overexpressed in the ab-
sence of the antibiotic), GRX5 expression was rapidly inhibited
(in less than 10 min) upon doxycycline addition. Under these
conditions, wild-type Grx5 had a half-life of about 4 h (Fig. 6, A
and B). This value was consistent with our previous observa-
tions showing that a strain in which the endogenous GRX5
promoter had been substituted for the tetO promoter displayed
the grx5-null phenotype about 12 h after inhibition of GRX5
expression (24). Amino acid substitutions that altered Grx5
activity did not significantly affect the stability of the protein
(Fig. 6B). This also applied for the F50E change that disrupted
one of the -strands in the region close to the active site. We
conclude that the amino acid changes studied in this work did
not alter the tertiary structure of Grx5 at a significant enough
level to negatively affect the protein stability.
DISCUSSION
Higher eukaryotes have cytosolic dithiol glutaredoxins,
which are required for maintaining the reduced status of pro-
tein thiol groups and for the activity of specific proteins (1, 2,
17–22). Furthermore, a mitochondrial dithiol glutaredoxin has
recently been described in human cells (38, 39). Its existence
reveals the importance of glutathione as a hydrogen donor for
protein disulfide groups not only in the cytoplasm, but also in
other cellular compartments. S. cerevisiae cells contain two
dithiol glutaredoxins (Grx1 and Grx2) that are located at the
cytosol and are highly homologous to other prokaryotic and
eukaryotic members of the family (40, 41). However, no typical
dithiol glutaredoxin seems to exist in yeast mitochondria. A
family of three proteins (Grx3, Grx4, and Grx5) has recently
been described in yeast. They all have glutaredoxin signatures
FIG. 2. Structure of S. cerevisiae Grx5 protein. Model for Grx5 three-dimensional structure (B) based on the structure of pig liver
thioltransferase (A). The latter was determined by x-ray crystallography (7). The structure of a simple thioredoxin fold, that of phage T4
glutaredoxin (6), is also shown (C). -Strands are represented as yellow arrows, -helices are represented as red spirals, and loops are colored gray.
FIG. 3. Location of essential residues in Grx5. Secondary struc-
ture elements are indicated as described in the Fig. 2 legend. -Helix
regions are numbered according to Ref. 15. The 4 region is positioned
toward the bottom of the model, almost at a right angle with respect
to 3.
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but contain a single cysteine residue at the conserved putative
active site (23). Based on this and the fact that both single
mutants and combinations of double mutants display reduced
glutaredoxin activity in cell extracts, we classified them as
monothiol glutaredoxins. Grx5 is mitochondrially located and
is involved in the maturation of Fe/S cluster-containing pro-
teins at the organelle matrix (24). Defects in grx5-null mutants
are common to mutants in other genes involved in Fe/S cluster
assembly (24, 42) and include sensitivity to oxidants, auxotro-
phy for amino acids whose biosynthesis requires Fe/S-contain-
ing enzymes, respiratory defects, and iron accumulation. The
function of yeast Grx5 is different from that of its human
homologue, the PICOT protein, which has been proposed as a
modulator of the protein kinase C- pathway (25, 27). Yeast
Grx3 and Grx4 are not mitochondrial, and their absence does
not cause the phenotypes observed in grx5 cells. On the other
hand, sequence alignment reveals that Grx3 and Grx4 are
closer relatives to PICOT than Grx5. This raises the possibility,
which has yet to be investigated, of a functional relationship
between Grx3/Grx4 and the PICOT protein. Taken together,
the above observations show a spatial and functional separa-
tion between yeast monothiol glutaredoxins.
Here we have centered our attention on the Grx5 structure-
function relationship. From studies with dithiol glutaredoxin
mutants in which one of the two Cys residues in the active site
was eliminated, it has been concluded that monothiol glutare-
doxins are active against mixed disulfides involving glutathi-
one and protein sulfhydryls (5, 43). A three-dimensional model
of Grx5, based on the known structure of a number of dithiol
glutaredoxins, is proposed. Grx5 has an obvious thioredoxin
fold structure. Cys60 (in the conserved PXCGFS region) lies
opposite the Gly115 and Gly116 residues conserved in both
monothiol and dithiol glutaredoxins. As in the dithiol molecules
(14, 44), this glycine pair forms a loop that could confer flexi-
bility for the appropriate positioning of 1 relative to 3 (Fig. 3).
Thus, the two 1 and 3 regions form the glutathione cleft with
the -sheet at the bottom. From structural studies involving
dithiol glutaredoxins, we can also deduce that other conserved
residues in Grx5 are important for the stabilization of gluta-
thione at the active site groove and its interaction with Cys60.
Asp118 is present at the 3 region of Grx5 and is conserved in
both glutaredoxin families (Ref. 23 and this work). It has been
proposed that this residue establishes an ionic interaction with
the -amino group of the glutamic acid residue of glutathione
(3, 13, 14). Lys20 of Grx5 is also conserved in both types of
glutaredoxins, and its amino group could interact electrostati-
cally with the -carboxylate of the carboxyl-terminal glycine of
glutathione (13, 14). Stabilization of glutathione in the cleft of
FIG. 4. Functional analysis of residues essential for the biological activity of Grx5. A scheme of Grx5 is shown in A, with the two
amino-terminal and carboxyl-terminal regions defined on the basis of homology to dithiol glutaredoxins (23). Sequences from the specific regions
where mutations were introduced are shown in detail, together with the polyglutamic acid tail at the carboxyl-terminal end. B, growth of wild-type
(MML161, top spots) and grx5 (MML160, bottom spots) cells in YPD medium before treatment (left panel) and after 45 min of treatment (middle
panel) with 10 mM menadione. Right panel shows growth in synthetic defined medium. C, summary of the growth characteristics of strains (see
Table I for strain name) carrying different amino substitutions in Grx5. Menadione treatment was as described in B;  denotes absence of growth
after treatment with the drug, such as in the case of the grx5 mutant in B;  denotes a growth pattern comparable with that of wild-type cells.
For growth in SD medium, the  and  symbols describe growth patterns similar to those shown in B for wild-type and mutant cells, respectively.
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E. coli Grx3 glutaredoxin could also involve ionic interaction
with an Arg40 residue (14). This residue is not present in all
dithiol glutaredoxins, but an equivalent Arg92 residue is pres-
ent in the 2-helix of Grx5 and is conserved in all the monothiol
glutaredoxins analyzed. It may therefore also contribute to
glutathione stabilization. A coiled region following the 2-helix
(Fig. 1) contains a number of conserved residues that could
contribute to stabilization of glutathione-mixed disulfide
through hydrogen bonds, by analogy to equivalent residues in
the E. coli Grx1 dithiol glutaredoxin (10).
To test the validity of our three-dimensional model for Grx5,
we introduced a number of amino acid substitutions in some of
the conserved residues and tested their effect on the biological
activity of the protein. Replacing Cys60 with a serine residue
totally eliminated activity, as did changing the following resi-
due (Gly61). However, the substitution of other residues in the
PKCGFS region had no effect on the phenotype. Only the
introduction of bulkier valine or serine side chains (but not
alanine) to replace glycine at position 61 seems to inhibit the
formation of glutathione mixed disulfide with Cys60. The sub-
stitution of either Gly115 or Gly116 for valine or serine residues
has the same effect as a grx5-null mutation. This supports the
role proposed above for this glycine pair in the formation of the
glutathione cleft. Each substitution would alter the orientation
of the 3-helix relative to 1 and the active cysteine in position
60, whereas a bulky side chain would impede access of the
glutathione molecule to the active site. We also hypothesized
that changing Phe50 for a residue such as glutamic acid would
alter the -sheet structure that delimits the glutathione cleft
and would make it difficult to appropriately position glutathi-
TABLE I
Yeast strains and inferred secondary structure at the amino acid
substitution positions
All strains are isogenic to wild-type S. cerevisiae CML235. The
strains listed were derived from MML19 by insertion of the correspond-
ing plasmids. Plasmids (YIplac211 vector or derivatives with wild-type
or GRX5 mutants) were integrated at the chromosomal LEU2 locus
after transformation with DNA that had been linearized by digestion at
the single EcoRV site within the plasmid LEU2 gene. The amino acid
replacements introduced in the GRX5 translation product are indi-
cated. The secondary structure elements at the amino acid substitution
positions are inferred from the model in Fig. 3.
Strain Plasmid Point mutation
Inferred
secondary
structure at
position
MML160 YIplac211 No insert
MML161 pMM25 Wild-type
GRX5
MML163 pMM27 C60S Coil
MML165 pMM28 C117S Helix
MML219 pMM76 F62S Helix
MML221 pMM77 P58V Coil
MML223 pMM78 K59Q Coil
MML225 pMM79 G116V Coil
MML273 pMM88 P58V K59Q Coil
MML274 pMM90 P58V F62S Coil, helix
MML276 pMM92 G115V Coil
MML322 pMM124 G61V Helix
MML374 pMM174 F50E Beta
MML421 pMM202 G115A Coil
MML423 pMM203 G115S Coil
MML425 pMM204 G61A Helix
MML427 pMM205 G61S Helix
FIG. 5. Iron concentration in Grx5 mutants with different
amino acid substitutions. Cultures of cells carrying the wild-type
gene (MML161) or the null grx5 mutation (MML160) or the mutations
that result in the indicated substitutions (see Table I for strain name)
were grown exponentially in YPD medium at 30 °C, and total iron
content per cell was determined (32). Mean cell volume was measured
in parallel to calculate iron concentration. Results for each strain are
the mean of three independent experiments; the differences between
the individual experiments were 20%.
TABLE II
Protein carbonyl content in Grx5 mutants with different
amino acid substitutions
Values ( S.D.) are the mean of at least three independent experi-
ments and are normalized with respect to wild-type (MML161) cells.
They correspond to nanomoles of carbonyl groups per milligram of cell
protein in exponentially growing cultures in YPD medium at 30 °C.
Absolute carbonyl content in MML161 cells was 0.70  0.02 nmol/mg
protein. Strains with the respective amino acid substitutions were those
indicated in Table I.
Grx5 amino acid substitution Relative carbonyl content
None 1.00
No Grx5 1.48  0.07
F50E 1.42  0.03
C60S 1.59  0.04
G61S 1.52  0.05
G115V 1.55  0.04
C117S 1.06  0.02
FIG. 6. Half-life of Grx5. CML276 cells transformed with plasmids
that expressed the wild-type GRX5 gene or different mutant derivatives
under the control of the tetO7 promoter were grown in YPD medium at
30 °C. At time 0, doxycycline (20 g/ml) was added to repress Grx5
synthesis. A, Western blot analysis of Grx5 in CML276 cells trans-
formed with pCM319. The same amount of total cell protein was loaded
for each sample. The left-most run corresponds to CML276 cells ex-
pressing only the chromosomal GRX5 gene under its own promoter. B,
quantification of Grx5 levels in samples taken at successive intervals
after doxycycline addition from Western blot analyses similar to that
shown in A. Transformants that expressed the indicated Grx5 forms
were used. At least two independent experiments were carried out for
each transformant.
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one relative to Cys60. In fact, this was the case: the F50E
change annulled the Grx5 activity.
Grx5 contains a second cysteine at position 117, which is not
required for the protein biological activity. This carboxyl-ter-
minal cysteine residue is also present at equivalent positions in
many, but not all, monothiol and dithiol glutaredoxins; Grx3
and Grx4, for instance, do not possess it. Mutation of this
cysteine in E. coli Grx3 has no effect on enzyme activity, and it
has been proposed that the residue could have a regulatory role
on the interaction of glutaredoxin with a second glutathione
molecule necessary in the dithiol mechanism of action (14).
There is, however, no evidence for such regulatory role in Grx5.
We have determined the half-life of the Grx5 protein using
the tet promoter to conditionally express GRX5. The same
result was obtained for the wild-type strain and for the differ-
ent mutants, which is an argument against major alterations
in the three-dimensional structure of the protein, even in the
case of amino acid replacements that cause loss of activity.
The absence of Grx5 causes a number of phenotypic effects
that are all closely related (24). Thus, the primary defect in the
assembly of Fe/S clusters would lead to (i) an inability to
synthesize a number of amino acids, (ii) respiratory growth
defects, and (iii) an accumulation of iron in the cell. As a
consequence of the latter, there is an accumulation of reactive
oxygen species in the cells, which in turn increases the level of
protein carbonyl groups and makes cells more sensitive to
external oxidants. Those amino acids substitutions that affect
the biological activity of Grx5 alter all the indicated phenotypes
in a similar way, including the ability for respiratory metabo-
lism (growth on glycerol medium). This confirms that all phe-
notype defects can be traced to the same loss of function. This
is independent of the fact that some substitutions (such as
F50E, G115S, and G116S) are expected to hinder the accessi-
bility and stabilization of glutathione at the active site,
whereas others (C60S and G61V) do not affect the access of the
glutathione moiety of mixed disulfides to the active site but
would affect the attack on the disulfide bond. Grx5 may be part
of a multiprotein complex involved in the mitochondrial assem-
bly of Fe/S clusters (24). The polyglutamic acid tail at the
carboxyl-terminal end (Fig. 4) could be important for interac-
tions with other proteins of the complex. The mutants used in
this work, among others, may facilitate the study of biochem-
ical reactions involving monothiol glutaredoxins and the spe-
cific role of Grx5 in Fe/S cluster assembly.
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